Cerebral venous thrombosis: Difference between revisions
Ostermayer (talk | contribs) |
Ostermayer (talk | contribs) |
||
Line 3: | Line 3: | ||
[[File:Cerebral veins.jpg|thumbnail|Cerebral Veins]] | [[File:Cerebral veins.jpg|thumbnail|Cerebral Veins]] | ||
*Occlusion of venous sinus (most commonly superior sagittal and lateral sinuses) by thrombus<ref>Piazza G. Cerebral venous thrombosis. Circulation 2012;125:1704-1709.</ref> | *Occlusion of venous sinus (most commonly superior sagittal and lateral sinuses) by thrombus<ref>Piazza G. Cerebral venous thrombosis. Circulation 2012;125:1704-1709.</ref> | ||
*No precise prevalence or incidence established due to rarity of condition | *No precise prevalence or incidence established due to rarity of condition. However the disease is more prevalent in patients with thrombilia, oral contraceptive use, and during pregnancy.<ref name="lancet">Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007; 6:162-70.</ref> | ||
*Median Age ~ 37 years | *Median Age ~ 37 years<ref name="lancet"></ref> | ||
*Female:Male ratio 3:1 | *Female:Male ratio 3:1<ref name="lancet"></ref> | ||
===Predisposing factors=== | ===Predisposing factors=== |
Revision as of 08:19, 11 October 2016
The cavernous sinus is one of the several cerebral veins and cavernous sinus thrombosis is a specific type of cerebral venous (sinus) thrombosis. See that article for a discussion of that specific clinical entity.
Background
- Occlusion of venous sinus (most commonly superior sagittal and lateral sinuses) by thrombus[1]
- No precise prevalence or incidence established due to rarity of condition. However the disease is more prevalent in patients with thrombilia, oral contraceptive use, and during pregnancy.[2]
- Median Age ~ 37 years[2]
- Female:Male ratio 3:1[2]
Predisposing factors
- Cancer
- Pregnancy
- Local infections (otitis media, sinusitis, cellulitis)
- Hypercoagulable states
- Trauma
- Drugs (ecstasy, androgens, OCPs)
- Compression of venous sinus (tumor, abscess)
Clinical Features
- Clinical presentation varies depending on location, acuity, and severity of thrombosis
- More gradual onset of symptoms or thrombosis allows for compensatory collateral venous system to develop
- Common Symptoms:
- Headache 74-92%
- Seizures 35-50%
- Papilledema 28-45%
- Focal Neurologic sequelae (seizures, dizziness) 25-71%
- Encephalopathy
Differential Diagnosis
Headache
Common
Killers
- Meningitis/encephalitis
- Myocardial ischemia
- Retropharyngeal abscess
- Intracranial Hemorrhage (ICH)
- SAH / sentinel bleed
- Acute obstructive hydrocephalus
- Space occupying lesions
- CVA
- Carbon monoxide poisoning
- Basilar artery dissection
- Preeclampsia
- Cerebral venous thrombosis
- Hypertensive emergency
- Depression
Maimers
- Giant cell arteritis of temporal artery (temporal arteritis)
- Idiopathic intracranial hypertension (Pseudotumor Cerebri)
- Acute Glaucoma
- Acute sinusitis
- Cavernous sinus thrombosis or cerebral sinus thrombosis
- Carotid artery dissection
Others
- Trigeminal neuralgia
- TMJ pain
- Post-lumbar puncture headache
- Dehydration
- Analgesia abuse
- Various ocular and dental problems
- Herpes zoster ophthalmicus
- Herpes zoster oticus
- Cryptococcosis
- Febrile headache (e.g. pyelonephritis, nonspecific viral infection)
- Ophthalmoplegic migraine
- Superior Vena Cava Syndrome
Aseptic Meningitis
- Viral
- Tuberculosis
- Lyme disease
- Syphilis
- Leptospirosis
- Fungal (AIDS, transplant, chemotherapy, chronic steroid use)
- Noninfectious
Evaluation
Suspect in patients presenting with headache, signs of increased ICP, or focal neurologic deficits in setting of any of above predisposing factors
- Imaging
- MRI/MRV considered diagnostic study of choice, now considered gold standard
- CT venography is a reasonable alternative
- Has been found to have similar sensitivity to MRV in recent studies
- Non contrast CT possesses insufficient sensitivity or specificity to be of diagnostic value in the setting of high clinical suspicion
- May see "Delta sign" dense triangle in superior sagittal sinus
- Labs
- D-Dimer has been proposed as a possible screening tool in low risk patients, but still needs further investigation
Management
Anticoagulation
- Heparin or low molecular weight heparin
- Of note, heparin initial bolus is 3000-5000U, lower than the dosing for PE/DVT
- Eventual transition to oral anticoagulation for a 3-6 month duration
Seizure prophylaxis
- Only required if the patient has a seizures
Supportive care
- Frequent neurologic checks and clinical monitoring for increased ICP
Acute Decompensation
- Consider
- Hemicraniectomy
- Intravascular thrombolytics
Disposition
- Admission
- To a level of care capable of frequent neurologic monitoring